RCAG
CME icon

Rehmann Capital Advisory Group’s CME Group CME Stock Holding History

Rehmann Capital Advisory Group’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269K Sell
910
-58
-6% -$17.2K 0.01% 576
2025
Q4 		$264K Buy
968
+70
+8% +$19K 0.01% 561
2025
Q3 		$243K Buy
898
+37
+4% +$10.1K 0.01% 568
2025
Q2 		$237K Buy
+861
New +$234K 0.01% 535
2023
Q2 		– Sell
-1,363
Closed -$261K – 553
2023
Q1 		$261K Buy
1,363
+79
+6% +$14.3K 0.02% 452
2022
Q4 		$216K Sell
1,284
-52
-4% -$9.04K 0.02% 502
2022
Q3 		$237K Sell
1,336
-425
-24% -$84K 0.03% 443
2022
Q2 		$361K Sell
1,761
-40
-2% -$8.48K 0.04% 340
2022
Q1 		$428K Buy
1,801
+110
+7% +$25.8K 0.04% 338
2021
Q4 		$400K Buy
1,691
+7
+0.4% +$1.54K 0.04% 364
2021
Q3 		$326K Sell
1,684
-66
-4% -$13.4K 0.03% 413
2021
Q2 		$372K Sell
1,750
-19
-1% -$4.01K 0.04% 384
2021
Q1 		$361K Buy
1,769
+409
+30% +$80.6K 0.04% 365
2020
Q4 		$248K Sell
1,360
-714
-34% -$121K 0.03% 422
2020
Q3 		$347K Sell
2,074
-45
-2% -$7.58K 0.04% 299
2020
Q2 		$344K Buy
2,119
+34
+2% +$6.09K 0.05% 301
2020
Q1 		$361K Buy
+2,085
New +$415K 0.06% 252
2019
Q3 		$544K Sell
2,574
-4,020
-61% -$840K 0.07% 160
2019
Q2 		$1.28M Buy
6,594
+240
+4% +$44.2K 0.16% 107
2019
Q1 		$1.05M Buy
6,354
+727
+13% +$129K 0.14% 119
2018
Q4 		$1.06M Buy
5,627
+3,977
+241% +$734K 0.16% 73
2018
Q3 		$281K Buy
1,650
+85
+5% +$14.3K 0.04% 314
2018
Q2 		$256K Buy
1,565
+93
+6% +$15.2K 0.04% 318
2018
Q1 		$238K Buy
1,472
+4
+0.3% +$637 0.04% 330
2017
Q4 		$214K Sell
1,468
-40
-3% -$5.7K 0.04% 360
2017
Q3 		$205K Sell
1,508
-263
-15% -$33.2K 0.04% 357
2017
Q2 		$222K Sell
1,771
-13
-0.7% -$1.55K 0.04% 326
2017
Q1 		$212K Buy
+1,784
New +$215K 0.04% 362

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rehmann Capital Advisory Group's CME Position: Q1 2026 in Review

Rehmann Capital Advisory Group reduced its CME Group (CME) stake by 6% in Q1 2026, selling an estimated $17.2K and leaving 910 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #576.

Rehmann Capital Advisory Group first reported a position in CME in Q1 2017 and has held it in 28 quarters since. The position peaked at $1.28M in Q2 2019. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Rehmann Capital Advisory Group held 910 shares of CME Group worth $269K as of Q1 2026.
  • Rehmann Capital Advisory Group sold 58 CME Group shares in Q1 2026, an estimated $17.2K.
  • CME Group made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #576 holding.
  • Rehmann Capital Advisory Group first reported a position in CME Group in Q1 2017 and has held it in 28 quarters since.
  • Rehmann Capital Advisory Group's CME Group position peaked at $1.28M in Q2 2019.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.